Saroglitazar Magnesium 4 mg in the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Women With PCOS (EVIDENCES VII)

NCT03617263 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

60

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Non-alcoholic Fatty Liver Disease in Women With PCOS

Interventions

DRUG: Saroglitazar Magnesium 4 mg Tablet
DRUG: Placebo

Sponsor

Zydus Therapeutics Inc.